Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures

Chemotherapy

Volumn 42, Issue 5, 1996, Pages 384-390

  Arnaboldi, L ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Antimicrobial prophylaxis; Ceftriaxone; Extracellular slime; Neurosurgery; Shunt infection

Indexed keywords

ANTIBIOTIC AGENT; CEFALOTIN; CEFTRIAXONE; CLOXACILLIN; GENTAMICIN; METICILLIN; NAFCILLIN; OXACILLIN; RIFAMPICIN; TRIMETHOPRIM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROSURGERY; PRIORITY JOURNAL; SHUNT INFECTION; SHUNTING; STAPHYLOCOCCUS EPIDERMIDIS;

ADULT; ANTIBIOTIC PROPHYLAXIS; CEFTRIAXONE; CEPHALOSPORINS; FEMALE; HUMANS; HYDROCEPHALUS; MALE; PROSPECTIVE STUDIES; TISSUE DISTRIBUTION; VENTRICULOPERITONEAL SHUNT;

EID: 0029839371     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239470     Document Type: Article

References (37)

1. Lampe S, Salama T, et al: Use of a surgical isolator for major surgery: Influence on wound contamination and postoperative wound infections; in Henegan JB (ed): Germ-Free Research. Biological Effect of Gnoto-biotic Environments. New York, Academic Press, 1973, pp 87-95.
2. Alvarez Garijo JA, Mengual MV: Infection rate with and without prophylactic antibiotic therapy after shunt infection for hydrocephalus. Monogr Neural Sei 1982;8:66-68.
3. Baldwin M, Fox DG: Laminar flow for the neurosurgical operating room. Technical note. J Neurosurg 1968;29:660-665.
4. Bayston R, Lari J: A study of the sources of infection in colonised shunts. Dev Med Child Neurol 1974;168:16-22.
5. Chamley J: Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop 1972;87:167-187.
6. Fulginiti VA, Sieber OF: Immune mechanisms in infectious diseases: in Stiehm ER, Fulginiti VA (eds): Immunologic Disorders in Infants and Children, ed 2. Philadelphia, Saunders, 1980, pp 687-701.
7. Beachey EH, Eisenstein BI, Ofck I: Bacterial Adherence in Infectious Disease. Current Concepts. Kalamazoo, Upjohn, 1982.
8. Costcrton JW, Irvin RT, et al: The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 1981; 35:299-324.
9. Concia E: II glicocalice quale fattore di patogenicita nelle infezioni da corpo cstranco. Pavia, Edimes, 1990.
10. Emmerson AM, Lamport PA, et al: The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics. Curr Med Res Opin 1985;9(7):480-493.
11. Bayston R: Hydrocephalus shunt infections. London, Chapman & Hall, 1989.
12. Schmidt K, et al: Antibiotic prophylaxis in cerebrospinal fluid shunting: A prospective randomized trial in 152 hydrocephalic patients. Neurosurgery 1985;17:1-5.
13. Yogev R: Cerebrospinal fluid shunt infections. A personal view. Pediatr Infect Dis 1985;4:113-118.
14. Bayston R: Hydrocephalus shunt infections and their treatment. Anti-microb Chemother 1985; 15:259-261.
15. Gardner P, et al: Infections of central nervous system shunts. Med Clin North Am 1985:69:297-314.
16. Bayston R, et al: Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989;52:605-609.
17. Bayston R, Rodgers J: Production of extracellular slime by Staphylococcus epidermidis during stationary' phase of growth: Its association with adherence to implantable device. J Clin Pathol 1990;43:866-870
18. Pople I, Bayston R, et al: Infection of cerebrospinal fluid shunts in infants: A study of etiological factors. J Neurosurg 1992;77:29-36.
19. Choux M, et al: Shunt implantation: Reducing the incidence of shunt infection. J Neurosurg 1992;77:875-880.
20. De Lalla F: Chemio-antibiotico-pro-filassi in chirurgia, ed 2. Milano, Masson, 1988.
21. Spector R: Ceftriaxone pharmacokinetics in the central nervous system. J Pharmacol Exp Ther 1986;236: 380-386.
22. Gardner P, et al: Infections of mechanical cerebrospinal fluid shunts; in Remington JS, Swartz MN (eds): Current Clinical Topics in Infectious Diseases. New York, McGraw-Hill, 1988, p 185.
23. Bassetti D, Solbiati M: Terapia delle infezioni batteriche con monodose giornaliera: Esperienze con ceftriaxone. Ter Mod 1988;2:6.
24. Bayston R: Antibiotic prophylaxis in shunt surgery. Dev Med Child Neurol Suppl 1975;35:99-103.
25. Djinjian M, Fcvricr MJ, Otterbein G, Soussy JC: Oxacillin prophylaxis in cerebrospinal fluid shunt procedures: Results of a randomized open study in 60 hydrocephalic patients. Surg Neurol 1986;25:178-180.
26. Haines SJ, Taylor F: Prophylactic methicillin for shunt operations: Effects on incidence of shunt malfunction and infection. Childs Brain 1982;9:10-22.
27. Schmidt K, Gjerris F, Osgaard O, et al: Antibiotic prophylaxis in cerebrospinal fluid shunting: A prospective randomized trial in 152 hydrocephalic patients. Neurosurgery 1985;17:1-5.
28. Yogev R, et al: Prophylaxis for ven-triculopcritoneal shunt surgery with nafcillin alone or in combination with rifampin; in 23rd Intersci-cnce Conference on Antimicrobial Agents and Chemotherapy. Las Vegas, American Society for Microbiology, 1983, abstr664.
29. Odio C, Mohs E, Sklar FH, Nelson JD, McCracken GH Jr: Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. Am J Dis Child 1984; 138:17-19.
30. Walters B, Goumnerova L, Hoffmann H, Humphreys R. Hendrick B: Perioperative antibiotic prophylaxis in shunt surgery; in Annual Meeting of the American Association of Neurological Surgeons. Washington. American Association of Neurological Surgeons, 1989. abstr 10.
31. Lambert M, MacKinnon AE, Vaish-nav A; Comparison of two methods of prophylaxis against CSF shunt infection. Z Kindcrchir 1984;39(suppl 2): 109-110.
32. Rcidcr MJ. Frewen TC, Del Maestro RF, Coyle A, Lovell S; The effect of ccphalothin prophylaxis on postoperative vcntriculopcritoneal shunt infections. Can Med Assoc J 1987;136:935-938.
33. Croci D, Biombini S, Boccazzi A: Ceftriaxone (CPO) prophylaxis of CNS shunt infections; in International Symposium on Perioperative Antibiotic Prophylaxis, San Juan. P.R., USA, March 4-7,1990. p 54.
34. Ades PE, Gavignet M, Lamotte C, et al: Prevention of infections with pc-floxacin during clean neurosurgery with known bacterial risk factors; in 1st International Conference on the Prevention of Infection, Nice, France, May 2-4,1990, abstr 187.
35. Martin E, et al: Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J Pediatr 1984; 105: 475-481.
36. Willital GH, Maragakis M, Schaarschmidt K: Indications, clinical results, blood and tissue concentrations of ceftriaxone in children’s surgery; in Adam D, ct al (eds): Recent Advances in Chemotherapy: Antimicrobial Section I. Proc 17th Int Congr Chcmothcr, Berlin 1991. Munich, Futuramed, 1992, pp 1210-1211.
37. Cohen J, Prado V, Banfi A, Cordero J, Ledermann W, Cofre J: Clinical and Bacteriological Efficacy of Ceftriaxone versus Standard Therapy in Children with Meningitis. Cologne. Medipress, 1988, vol 4 (suppl 2), pp 23-28.